PR Release Shilpa Medicare Announces Positive Phase 3 Results for OERIS™ — A Novel Once-Weekly Ondansetron Extended-Release Injection for Chemotherapy-Induced Nausea and Vomiting (CINV) November 12, 2025 gopalkumarthakur@gmail.com Related posts: PUNJAB CM TAKES STOCK OF RELIEF AND RESCUE MEASURES IN FLOOD AFFECTED HOSHIARPUR DISTRICT Every flood victim will get compensation within 45 days: CM Mann Herbalife Strengthens Enduring Partnership with IRONMAN 70.3 GOA, INDIA for its Fifth Edition Air Serbia and Loyalty Juggernaut Partner to Launch a Next-Generation Frequent Flyer Program
